These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 15711884

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animals.
    Hinkle RT, Lefever FR, Dolan ET, Reichart DL, Zwolshen JM, Oneill TP, Maloney KG, Mattson JP, Ferreira LF, Musch TI, Poole DC, Isfort RJ.
    BMC Musculoskelet Disord; 2011 Jan 14; 12():15. PubMed ID: 21235761
    [Abstract] [Full Text] [Related]

  • 5. Discovery of corticotropin releasing factor 2 receptor selective sauvagine analogues for treatment of skeletal muscle atrophy.
    Isfort RJ, Wang F, Tscheiner M, Donnelly E, Bauer MB, Lefever F, Hinkle RT, Mazur AW.
    J Med Chem; 2005 Jan 13; 48(1):262-5. PubMed ID: 15634020
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of a CRF2R agonist and exercise on mdx and wildtype skeletal muscle.
    Hall JE, Kaczor JJ, Hettinga BP, Isfort RJ, Tarnopolsky MA.
    Muscle Nerve; 2007 Sep 13; 36(3):336-41. PubMed ID: 17503504
    [Abstract] [Full Text] [Related]

  • 8. Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions.
    Reichart DL, Hinkle RT, Lefever FR, Dolan ET, Dietrich JA, Sibley DR, Isfort RJ.
    BMC Musculoskelet Disord; 2011 Jan 26; 12():27. PubMed ID: 21269506
    [Abstract] [Full Text] [Related]

  • 9. [Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle].
    Deng XH, Shi J, Luo SQ, He C, Wang CH, Lu CL.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2001 May 26; 17(2):148-52. PubMed ID: 21171403
    [Abstract] [Full Text] [Related]

  • 10. Determinants of corticotropin releasing factor. Receptor selectivity of corticotropin releasing factor related peptides.
    Mazur AW, Wang F, Tscheiner M, Donnelly E, Isfort RJ.
    J Med Chem; 2004 Jun 17; 47(13):3450-4. PubMed ID: 15189041
    [Abstract] [Full Text] [Related]

  • 11. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE, Liu XJ, Vaughn J, Palmer SF, True CD, Vale WW, Ling N, De Souza EB.
    Mol Pharmacol; 1996 Sep 17; 50(3):679-86. PubMed ID: 8794910
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery.
    Schilling L, Kanzler C, Schmiedek P, Ehrenreich H.
    Br J Pharmacol; 1998 Nov 17; 125(6):1164-71. PubMed ID: 9863643
    [Abstract] [Full Text] [Related]

  • 13. Effects of chronic electrical stimulation on contractile properties of long-term denervated rat skeletal muscle.
    al-Amood WS, Lewis DM, Schmalbruch H.
    J Physiol; 1991 Sep 17; 441():243-56. PubMed ID: 1816374
    [Abstract] [Full Text] [Related]

  • 14. Interrelations of myogenic response, progressive atrophy of muscle fibers, and cell death in denervated skeletal muscle.
    Borisov AB, Dedkov EI, Carlson BM.
    Anat Rec; 2001 Oct 01; 264(2):203-18. PubMed ID: 11590596
    [Abstract] [Full Text] [Related]

  • 15. Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
    Argilés JM, Figueras M, Ametller E, Fuster G, Olivan M, de Oliveira CC, López-Soriano FJ, Isfort RJ, Busquets S.
    Muscle Nerve; 2008 Feb 01; 37(2):190-5. PubMed ID: 17912749
    [Abstract] [Full Text] [Related]

  • 16. Cell death in denervated skeletal muscle is distinct from classical apoptosis.
    Borisov AB, Carlson BM.
    Anat Rec; 2000 Mar 01; 258(3):305-18. PubMed ID: 10705351
    [Abstract] [Full Text] [Related]

  • 17. Changes in some troponin and insulin-like growth factor messenger ribonucleic acids in regenerating and denervated skeletal muscles.
    Krishan K, Dhoot GK.
    J Muscle Res Cell Motil; 1996 Oct 01; 17(5):513-21. PubMed ID: 8906619
    [Abstract] [Full Text] [Related]

  • 18. Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats.
    Ryall JG, Plant DR, Gregorevic P, Sillence MN, Lynch GS.
    J Physiol; 2004 Feb 15; 555(Pt 1):175-88. PubMed ID: 14617677
    [Abstract] [Full Text] [Related]

  • 19. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells.
    Heldwein KA, Redick DL, Rittenberg MB, Claycomb WC, Stenzel-Poore MP.
    Endocrinology; 1996 Sep 15; 137(9):3631-9. PubMed ID: 8756527
    [Abstract] [Full Text] [Related]

  • 20. Corticotropin-releasing factor 2 receptor localization in skeletal muscle.
    Samuelsson S, Lange JS, Hinkle RT, Tarnopolsky M, Isfort RJ.
    J Histochem Cytochem; 2004 Jul 15; 52(7):967-77. PubMed ID: 15208363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.